Pulmonary and Allergy Medicine

Medicine & Life Sciences

1. Pulmonary Arterial Hypertension 100%
2. Pulmonary Hypertension 55%
3. Lung 49%
4. Registries 30%
5. treprostinil 27%
6. Bronchiectasis 26%
7. Lymphangioleiomyomatosis 20%
8. Therapeutics 18%
9. Interstitial Lung Diseases 17%
10. Pneumonia 16%
11. Lung Diseases 15%
12. Intensive Care Units 14%
13. Chronic Obstructive Pulmonary Disease 13%
14. Pressure 13%
15. Pulmonary Artery 13%
16. Nontuberculous Mycobacteria 12%
17. Adrenal Cortex Hormones 12%
18. Familial Primary Pulmonary Hypertension 11%
19. Adult Respiratory Distress Syndrome 11%
20. Bronchoscopy 11%
21. Idiopathic Pulmonary Fibrosis 11%
22. Dyspnea 11%
23. Epoprostenol 11%
24. Hypertension 10%
25. Survival 10%
26. Liver Transplantation 10%
27. Coronavirus 10%
28. Hemodynamics 10%
29. Cardiac Catheterization 10%
30. Thorax 9%
31. Critical Illness 9%
32. Mortality 9%
33. Hospitalization 9%
34. Obstructive Sleep Apnea 9%
35. Gastroesophageal Reflux 8%
36. Artificial Respiration 8%
37. Restless Legs Syndrome 8%
38. Respiratory Insufficiency 8%
39. Tomography 8%
40. Antineutrophil Cytoplasmic Antibodies 8%
41. Physicians 8%
42. Fibrosis 8%
43. Safety 7%
44. Acute Lung Injury 7%
45. Catamenial pneumothorax 7%
46. Sleep 7%
47. Pneumonectomy 7%
48. Pandemics 7%
49. Morbidity 7%
50. Vascular Resistance 7%
51. Arterial Pressure 6%
52. Cohort Studies 6%
53. Prostaglandins I 6%
54. Robotics 6%
55. Atrial Pressure 6%
56. Clinical Trials 6%
57. Asthma 6%
58. Incidence 6%
59. Neutrophils 6%
60. Air Embolism 6%
61. Needles 6%
62. Guidelines 5%
63. Lung Neoplasms 5%
64. Connective Tissue Diseases 5%
65. Health 5%
66. Patient Care 5%
67. alpha-Linolenic Acid 5%
68. Air 5%
69. Infections 5%
70. Exercise 5%
71. Arachidonic Acid 5%
72. Randomized Controlled Trials 5%
73. Induced Hypothermia 5%
74. Cystic Disease Of Lung 5%
75. Amiodarone 5%
76. Eicosanoids 5%
77. Emphysema 5%
78. Central Venous Catheters 5%
79. Sirolimus 5%
80. macitentan 5%
81. Confidence Intervals 5%
82. riociguat 5%